USV Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Glycomet Trio 1/0.3 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glycomet Trio 1/0.3 Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glycomet Trio 1/0.3 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glycomet Trio 1/0.3 Tablet SR.
Glycomet Trio 1/0.3 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glycomet Trio 1/0.3 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glycomet Trio 1/0.3 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. Carry a sugar source with you for immediate relief in case of hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glycomet Trio 1/0.3 Tablet SR is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken with proper diet and exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin works by lowering glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels. This combination is not indicated for the treatment of Type 1 DM.
Possible side effects of Glycomet Trio 1/0.3 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
It is important to avoid using Glycomet Trio 1/0.3 Tablet SR if you are allergic to any of its components or excipients. Patients with moderate to severe kidney disease and inflammatory bowel disease (IBD) should also avoid this medication, as well as those with colonic ulcers or underlying metabolic acidosis including diabetic ketoacidosis.
No, it is not recommended to drink alcohol while taking Glycomet Trio 1/0.3 Tablet SR. Alcohol can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, using Glycomet Trio 1/0.3 Tablet SR can lead to hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feeling anxious or shaky. This is more likely if you miss meals, drink alcohol, over-exercise or take other antidiabetic medications together with it. Regular monitoring of blood glucose levels is crucial. Always keep glucose tablets, honey or fruit juice readily available.
Keep this medication in its original container, tightly closed. Store according to the directions on the packaging or label. Never use expired medication, and do not give it to children or pets.